RMD - ResMed Inc.
97.20 0.00 (0.00%)
After hours: 5:02PM EDT
| Previous Close | 96.45 |
| Open | 96.40 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 95.81 - 97.47 |
| 52 Week Range | 67.04 - 104.78 |
| Volume | 697,845 |
| Avg. Volume | 638,220 |
| Market Cap | 13.893B |
| Beta | 1.29 |
| PE Ratio (TTM) | 48.92 |
| EPS (TTM) | 1.99 |
| Earnings Date | Apr 25, 2018 - Apr 30, 2018 |
| Forward Dividend & Yield | 1.40 (1.42%) |
| Ex-Dividend Date | 2018-02-07 |
| 1y Target Est | 86.21 |
- Associated Press•4 hours ago
ResMed: Fiscal 3Q Earnings Snapshot
The San Diego-based company said it had net income of 76 cents per share. Earnings, adjusted for amortization costs and restructuring costs, came to 92 cents per share. The results beat Wall Street expectations. ...
- Business Wire•5 hours ago
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2018
ResMed today announced results for its quarter ended March 31, 2018. Revenue for the quarter was $591.6 million, a 15 percent increase compared to the same period of the prior year.
- Zacks•5 hours ago
Integra LifeSciences (IART) Tops on Q1 Earnings, '18 View Up
Integra LifeSciences' (IART) revenue growth was primarily driven by high organic revenues, successful progress with Codman integration and progress with the channel expansion strategy.
- Zacks•yesterday
Thermo Fisher (TMO) Q1 Earnings Beat Estimates, '18 View Up
Thermo Fisher's (TMO) performance in Q1 benefits from a series of product launches alongside a major progress in precision medicine initiatives.
- Zacks•yesterday
Illumina (ILMN) Beats on Q1 Earnings, Lifts '18 Guidance
Illumina's (ILMN) collaboration with Bristol-Myers Squibb and Loxo Oncology are likely to yield results in the near term.
- Zacks•yesterday
Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss
Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q1.
- Zacks•yesterday
Medical Product Stock Earnings Roster for Apr 26: BAX & More
Let's take a look at the factors that are likely to impact the earnings results of a few MedTech bigwigs within the broader Medical universe.
- Motley Fool•3 days ago
Checking In on 5 Stocks for April the Giraffe, 1 Year Later
David stuck his neck out to make these recommendations.
- GlobeNewswire•4 days ago
Analysis: Positioning to Benefit within Korn/Ferry International, ResMed, Donaldson, Ollie's Bargain Outlet, VSE, and STARWOOD PROPERTY TRUST, INC — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, April 23, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Zacks•7 days ago
Can ResMed (RMD) Repeat Stable Device Growth in Q3 Earnings?
ResMed's (RMD) sleep apnea patient volume consistently witnesses a steady expansion. We expect this upside to continue in the fiscal third quarter as well.
- Business Wire•20 days ago
Company Profile for ResMed
ResMed , a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath.
- Business Wire•24 days ago
ResMed Hires Bobby Ghoshal as First Chief Technology Officer
ResMed today announced the hire of its first chief technology officer , Bobby Ghoshal, effective today.
- Business Wire•28 days ago
ResMed to Announce Third Quarter Fiscal Year 2018 Results
ResMed today announced it will report its third quarter of fiscal year 2018 results on Thursday, April 26, 2018, after the New York Stock Exchange market closes. A press release with ResMed’s results will be issued after 1:00 p.m.
- Zacks•28 days ago
Global Expansion and Product Launches to Aid ResMed's Growth
ResMed (RMD) continues to benefit from solid sales of sleep devices, respiratory care devices, mask systems and software solutions globally.
- Zacks•last month
Here's Why You Must Add ResMed (RMD) to Your Portfolio Now
ResMed (RMD) boosts investor confidence on strength in Software-as-a-Service businesses as well as new mask products and devices.
Markit•last monthSee what the IHS Markit Score report has to say about ResMed Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding RMD totaled $1.87 billion.
- Zacks•2 months ago
Here's Why Teleflex Has Been Losing Ground Since Q4 Earnings
Teleflex's (TFX) contracted Q4 adjusted operating margin is discouraging.
- Zacks•2 months ago
ResMed (RMD) Rides High on Robust Global Growth & Innovation
ResMed (RMD) consistently invests and expands globally in high-growth markets like China, South Korea, India, Brazil and across the Eastern Europe belt.
- PR Newswire•2 months ago
Brightree Showcasing Next-Generation Interoperability Experiences at HIMSS18
ATLANTA , Feb. 28, 2018 /PRNewswire/ -- Brightree, a leading provider of cloud-based software to improve clinical and business performance of post-acute care companies, will show how interoperability and ...
- Zacks•2 months ago
Why Is ResMed (RMD) Down 7.5% Since the Last Earnings Report?
ResMed (RMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GlobeNewswire•2 months ago
New Research: Key Drivers of Growth for ResMed, Qorvo, Integrated Device Technology, Cimarex Energy, Las Vegas Sands, and Echelon — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Feb. 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ResMed ...
Markit•2 months agoSee what the IHS Markit Score report has to say about ResMed Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- PR Newswire•3 months ago
GEMCO Medical Announces Brightree Partnership
Providing more Purchasing Power for Providers at no Additional Cost. HUDSON, Ohio , Feb. 7, 2018 /PRNewswire/ -- GEMCO Medical, a distributor for medical supply providers, is pleased to announce its partnership ...
- Zacks•3 months ago
Haemonetics' (HAE) Q3 Earnings Top Estimates, EPS View Up
Continued momentum in new business generation and geographical expansions drive Haemonetics (HAE) in the third quarter.
- Zacks•3 months ago
LabCorp (LH) Q4 Earnings Beat Estimates, '18 View Promising
LabCorp's (LH) Covance Drug Development of late begins to gain traction from Chiltern acquisition, strong organic growth and a favorable foreign currency translation.
